Management of central nervous system demyelinating diseases during the coronavirus disease 2019 pandemic: a practical approach

Management of central nervous system demyelinating diseases during the coronavirus disease 2019 pandemic: a practical approach

ABSTRACT Background: The novel coronavirus disease 2019 (COVID-19) pandemic poses a potential threat to patients with autoimmune disorders, including multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). Such patients are usually treated with immunomodulatory or immunosuppres...

Full description

Bibliographic Details
Main Authors: Samira Luisa APÓSTOLOS-PEREIRA, Guilherme Diogo SILVA, Caio César Diniz DISSEROL, Lucas Bueno FEO, Aline de Moura Brasil MATOS, Vinicius Andreoli SCHOEPS, Ana Beatriz Ayroza Galvão Ribeiro GOMES, Mateus BOAVENTURA, Maria Fernanda MENDES, Dagoberto CALLEGARO
Format: Article
Language:English
Published: Academia Brasileira de Neurologia (ABNEURO) 2020-07-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
Multiple Sclerosis
Neuromyelitis Optica Spectrum Disorders
Coronavirus
Immunosuppressive Agents
Drug Side Effects
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000700430&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2020000700430&tlng=en

Similar Items